Definitive Contract HT942523C0078
Award Date
9/29/23
Potential Completion Date
11/28/25
Potential Value
$3.9M
Federal Agency
Defense Health Agency
Awardee
Hexamer Therapeutics Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pullman, WA 99163, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>
<p>This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Grapheno, LLC, a small business, under the SBIR Phase I program. The contract is for the development of a "HALOVAX: Clay Nanotube-Based Vaccine Delivery Patches for the Sustained Release of an HIV Vaccine" as medical research and development. The contract has a ceiling value of $249,978.59 and a period of performance ending on August 26, 2025.</p>
<p>This is a $249,987.98 firm fixed price SBIR Phase I research and development contract awarded by the Defense Health Agency (DHA) to Hera Health Solutions Inc., a minority-owned small disadvantaged business. The contract is for the development of a "Drug Delivery Platform for the Sustained Release of an HIV Vaccine" under the DHA SBIR program. The contract has a period of performance through August 26, 2025 and was set aside for small businesses.</p>
This is a $180,000 fixed-price purchase order awarded by the Defense Health Agency (DHA) to Genovac Antibody Discovery LLC, a small disadvantaged business, to provide human monoclonal antibody (mAb) development services. The contract supports the Walter Reed Army Institute of Research (WRAIR) and Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS) and includes performing feasibility studies, developing and producing a panel of fully human mAbs, and shipping the mAbs to AFRIMS...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
<p>This is a $249,723.49 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Solaris Vaccines, Inc. under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a "VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS." The contract has a total small business set-aside and an ultimate completion date of January 20, 2025.</p>
<p>This is a $149,987.54 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nano Terra, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The award is for the "SBIR PHASE I DHP H161-010-0050" effort, which falls under the SBIR (Small Business Innovation Research) program. The contract has a performance period from August 15, 2016 to March 16, 2017 and is designated as a Total Small Business set-aside.</p>
This is a $2,999,999.66 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to JAN Biotech, Inc. (JBI), a woman-owned small business. The contract is for JBI to provide research and development services under the Small Business Innovation Research (SBIR) program, specifically for sample collection and processing methods to support battlefield wound infection diagnostics. The contract has a total small business set aside designation and a performance period ending on January...
This is a $1,159,290,240.64 cost-plus-award-fee contract awarded by the Department of the Army Medical Command to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract, which has no set-aside designation, is for research, development, manufacturing, and testing services to support biopharmaceutical products targeting infectious diseases. Dynport has provided similar services under past federal contracts with NIH, HHS, and the Joint Program Executive Office for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PEDVAXHIB vaccine vials in 0.5 ml doses, with a ceiling value of $5,838.00 and an ultimate completion date of August 15, 2024. The contract is not set-aside and is part of a larger indefinite delivery contract (IDC) vehicle held by DMS...